Hypersensitivity to the active substances or to any of the excipients. Due to the content of calcipotriol, calcipotriol hydrate and betamethasone dipropionate (Daivobet) is contraindicated in patients with known disorders of calcium metabolism.
Due to the content of corticosteroid, Calcipotriol hydrate and betamethasone dipropionate (Daivobet) is contraindicated in the following conditions: Viral (eg. herpes or varicella) lesions of the skin, fungal or bacterial skin infections, parasitic infections, skin manifestations in relation to tuberculosis, rosacea, perioral dermatitis, acne vulgaris, atrophic skin, striae atrophicae, fragility of skin veins, ichthyosis, acne rosacea, ulcers and wounds.
Calcipotriol hydrate and betamethasone dipropionate (Daivobet) is contraindicated in erythrodermic, exfoliative and pustular psoriasis.
Other Services
Country
Account